Point72 Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8M | Sell |
|
|||||
|
2025
Q1 | $35.3M | Sell |
|
|||||
|
2024
Q4 | $49.8M | Buy |
|
|||||
|
2024
Q3 | $36.3M | Buy |
|
|||||
|
2024
Q2 | $22.2M | Buy |
|
|||||
|
2024
Q1 | $2.84M | Sell |
|
|||||
|
2023
Q4 | $4.9M | Sell |
|
|||||
|
2023
Q3 | $25.5M | Buy |
|
|||||
|
2023
Q2 | $19.6M | Sell |
|
|||||
|
2023
Q1 | $55.6M | Buy |
|
|||||
|
2022
Q4 | $33.7M | Buy |
|
|||||
|
2022
Q3 | $14.5M | Buy |
|
|||||
|
2022
Q2 | $16.3M | Sell |
|
|||||
|
2022
Q1 | $23.1M | Sell |
|
|||||
|
2021
Q4 | $35.8M | Buy |
|
|||||
|
2021
Q3 | $30.7M | Sell |
|
|||||
|
2021
Q2 | $67.4M | Buy |
|
|||||
|
2021
Q1 | $13.6M | Sell |
|
|||||
|
2020
Q4 | $16.6M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $5.02M | Buy |
|
|||||
|
2019
Q3 | $2.39M | Buy |
|
|||||
|
2019
Q2 | $2.18M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $7.55M | Buy |
|
|||||
|
2018
Q3 | $2.67M | Sell |
|
|||||
|
2018
Q2 | $4.61M | Sell |
|
|||||
|
2018
Q1 | $3.57M | Sell |
|
|||||
|
2017
Q4 | $4.33M | Buy |
|
|||||
|
2017
Q3 | $2.66M | Sell |
|
|||||
|
2017
Q2 | $4.04M | Sell |
|
|||||
|
2017
Q1 | $5.42M | Buy |
|